Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet

Pablo F Hockl1, Alejandro Wolosiuk2, Juan M Pérez-Sáez1

  • 1Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Vuelta de Obligado 2490, C1428ADN Buenos Aires, Argentina.

Pharmacological Research
|February 9, 2016
PubMed

Insights

Altered cell surface glycans in the tumor microenvironment influence cancer progression. Targeting these glycan-binding proteins (lectins) offers novel therapeutic strategies.

Area of Science:

  • Oncology
  • Glycobiology
  • Immunology

Background:

  • Tumor microenvironment exhibits significant changes in glycan-related gene expression.
  • Glycosylation alterations impact cancer cells and associated stromal, endothelial, and immune cells.
  • Specific glycan changes include branched N-glycans, mucins, and altered sialylation.

Purpose of the Study:

  • To review the biological relevance of lectin-glycan interactions in the tumor microenvironment.
  • To explore the potential of targeting these interactions for cancer therapy.
  • To discuss the design of nanoparticles for delivering therapeutic agents targeting lectin-glycan interactions.

Main Methods:

  • Literature review focusing on glycan alterations and lectin-glycan interactions in cancer.
  • Analysis of the role of galectin-1 in immunosuppression and angiogenesis.
  • Discussion of nanoparticle-based drug delivery strategies for targeting lectin-glycan pathways.

Main Results:

  • Glycan alterations in the tumor microenvironment can modulate ligand availability for endogenous lectins.
  • Galectin-1 demonstrates immunosuppressive and pro-angiogenic activities within the tumor microenvironment.
  • Functionalized nanoparticles offer a platform for delivering multimeric glycans, lectins, or inhibitors.

Conclusions:

  • Differential glycan expression presents opportunities for novel cancer biomarkers.
  • Targeting lectin-glycan interactions holds therapeutic potential against cancer.
  • Nanoparticle-mediated delivery systems can be designed to exploit these interactions for antitumor activity.

Related Concept Videos

Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
10.4K
Glycocalyx and its Functions01:14

Glycocalyx and its Functions

The glycocalyx is a carbohydrate-rich, fuzzy-appearing layer on the outer surface of the cell membrane. It is highly hydrophilic, because of this it attracts large amounts of water to the cell's surface. This aids the cell's interaction with the watery environment and also helps it to obtain substances dissolved in the water. It is also important for cell identification, self/non-self determination, and embryonic development and is used in cell-to-cell attachments to form tissues.
10.2K
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
7.6K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K